AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

13.76 +0.02 (+0.11%)

Delayed Quote Updated: 3:40 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies ↗

April 28, 2023

Check out these compelling opportunities.

Via The Motley Fool

7 Stocks Under $10 That Analysts Love ↗

April 24, 2023

While these ideas might seem super cheap in a bad way, these stocks under $10 also rank among Wall Street analysts’ top picks.

Via InvestorPlace

AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023

April 17, 2023

From AbCellera Biologics Inc.

Via Business Wire

1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy ↗

April 13, 2023

These companies are leading the way in using AI in healthcare.

Via The Motley Fool

4 Analysts Have This to Say About AbCellera Biologics ↗

February 28, 2023

Via Benzinga

Preview: AbCellera Biologics's Earnings ↗

February 20, 2023

Via Benzinga

The Latest Analyst Ratings for AbCellera Biologics ↗

January 06, 2023

Via Benzinga

7 Best Stocks Under $10 to Buy in April ↗

April 11, 2023

Although these stocks under $10 to buy may be cheap, their underlying businesses could yield significant upside.

Via InvestorPlace

AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023

April 11, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023

April 06, 2023

From AbCellera Biologics Inc.

Via Business Wire

7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗

April 05, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

Via InvestorPlace

7 Stocks to Bet On if You Want to Be Richer Than Elon Musk ↗

March 22, 2023

If you can handle the heat of extreme speculation, you may want to throw some gambling funds at these stocks that can make you rich.

Via InvestorPlace

AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease

March 22, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023

March 14, 2023

From AbCellera Biologics Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 ↗

February 28, 2023

Via Benzinga

AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023

February 23, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript ↗

February 21, 2023

ABCL earnings call for the period ending December 31, 2022.

Via The Motley Fool

AbCellera Reports Full Year 2022 Business Results

February 21, 2023

From AbCellera Biologics Inc.

Via Business Wire

The 7 Most Undervalued Biotech Stocks to Buy in February 2023 ↗

February 02, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

Via InvestorPlace

AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023

February 01, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Report Full Year 2022 Financial Results on February 21, 2023

January 24, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent

January 19, 2023

From AbCellera Biologics Inc.

Via Business Wire

AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023

January 04, 2023

From AbCellera Biologics Inc.

Via Business Wire

RCI Hospitality, AbCellera Biologics And Some Other Big Stocks Moving Higher On Thursday ↗

December 15, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 600 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

AbCellera and AbbVie Partner to Advance New Antibody Therapies

December 15, 2022

From AbCellera Biologics Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022 ↗

December 15, 2022

Via Benzinga

Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket ↗

December 15, 2022

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.

Via Benzinga

Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket ↗

December 13, 2022

Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.

Via Benzinga

Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

December 13, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. ACM Research, Inc. (NASDAQ: ACMR) shares jumped 25.9% to $10.98 in...

Via Benzinga

AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases

December 01, 2022

From Rallybio Corporation

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.